The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Genetic association studies are viewed as problematic and plagued by irreproducibility. Many associations have been reported for type 2 diabetes, but none have been confirmed in multiple samples and with comprehensive controls. We evaluated 16 published genetic associations to type 2 diabetes and related sub-phenotypes using a family-based design to control for population stratification, and replication samples to increase power. We were able to confirm only one association, that of the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-gamma(PPARgamma) with type 2 diabetes. By analysing over 3,000 individuals, we found a modest (1.25-fold) but significant (P=0.002) increase in diabetes risk associated with the more common proline allele (85% frequency). Moreover, our results resolve a controversy about common variation in PPARgamma. An initial study found a threefold effect, but four of five subsequent publications failed to confirm the association. All six studies are consistent with the odds ratio we describe. The data implicate inherited variation in PPARgamma in the pathogenesis of type 2 diabetes. Because the risk allele occurs at such high frequency, its modest effect translates into a large population attributable risk-influencing as much as 25% of type 2 diabetes in the general population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The other known T2D susceptibility variants were detected with effect sizes consistent with previous reports (2, 3).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [2]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [2]
In the citing paper
“Whereas an initial positive report (61) had not been confirmed in four modest-sized replication studies, larger studies produced strong and consistent evidence of increased risk by a factor of 1.2 (62, 63). The negative studies were actually consistent with the level of increased risk, but simply lacked adequate power to detect it.”
From Genetic Mapping in Human Disease (2008) · cites this paper as [62]
Citations
Cites
Spielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993) · PubMed · Cited by 3,651
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368 · cited 1×
“Third, although much can be learned from rare genetic variants (such as seven patients carrying rare amino acid changes in PPARγ; ref”
BackgroundDeeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Cloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
A Sibship Test for Linkage in the Presence of Association: The Sib Transmission/Disequilibrium Test
Spielman, R. S., & Ewens, W. J. (1998) · The American Journal of Human Genetics · doi:10.1086/301714 · Cited by 659
Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641
Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation
Ristow, M., Müller-Wieland, D., Pfeiffer, A., Krone, W., & Kahn, C. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391403 · Cited by 545
Widén, E., Lehto, M., Kanninen, T., Walston, J., Shuldiner, A. R., & Groop, L. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330604 · Cited by 541
Self-citation
Cited by
Items 301–400 of 1,003
Human population structure and genetic association studies
Ziv, E., & Burchard, E. G. (2003) · Pharmacogenomics · doi:10.1517/phgs.4.4.431.22758 · Cited by 119
The next generation of PPAR drugs: Do we have the tools to find them?
SHEARER, B. G., & Billin, A. N. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.05.005 · Cited by 119
The Genetic Basis of Complex Traits
Iyengar, S. K., & Elston, R. C. (2007) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-389-9_6 · Cited by 118
Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo
Soccio, R. E., Chen, E. R., Rajapurkar, S. R., Safabakhsh, P., Marinis, J. M., Dispirito, J. R., Emmett, M. J., Briggs, E. R., Fang, B., Everett, L. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.025 · Cited by 117
KANG, E., PARK, S., KIM, H., KIM, C., AHN, C., CHA, B., LIM, S., NAM, C., & LEE, H. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.04.013 · Cited by 117
Blüher, M., Lübben, G., & Paschke, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.825 · Cited by 117
The Genetics of Type 2 Diabetes: A Realistic Appraisal in 2008
Florez, J. C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1345 · Cited by 117
Multi-omics profiling: the way toward precision medicine in metabolic diseases
Hu, C., & Jia, W. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab051 · Cited by 117
Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
Mannino, G. C., Andreozzi, F., & Sesti, G. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3109 · Cited by 117
New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function
Perry, J. R., & Frayling, T. M. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32830349a1 · Cited by 117
Diabetes in China: epidemiology, pathophysiology and multi-omics
Jia, W., Chan, J. C. N., Wong, T. Y., & Fisher, E. B. (2025) · Nature Metabolism · doi:10.1038/s42255-024-01190-w · Cited by 116
Developmental Origins of Health and Disease – from a small body size at birth to epigenetics
Eriksson, J. G. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1193786 · Cited by 115
Shaat, N., Lernmark, Å., Karlsson, E., Ivarsson, S. A., Parikh, H. M., Berntorp, K. E., & Groop, L. (2007) · Diabetologia · doi:10.1007/s00125-007-0623-2 · Cited by 115
Self-citationIdentification of Type 2 Diabetes-associated combination of SNPs using Support Vector Machine
Ban, H., Heo, J. Y., Oh, K.-S., & Park, K.-J. (2010) · BMC Genetics · doi:10.1186/1471-2156-11-26 · Cited by 115
Familial Clustering of Chronic Kidney Disease
Satko, S. G., Sedor, J. R., Iyengar, S. K., & Freedman, B. I. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00282.x · Cited by 115
Common Genetic Variation in IGF1 and Prostate Cancer Risk in the Multiethnic Cohort
Cheng, I. C., Stram, D. O., Penney, K. L., Pike, M. C., Marchand, L. L., Kolonel, L. N., Hirschhorn, J. N., Altshuler, D., Henderson, B. E., & Freedman, M. L. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj013 · Cited by 114
Self-citationA new expression of diabetes: double diabetes
Pozzilli, P., & Buzzetti, R. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.12.003 · Cited by 114
Genetic and nutrient determinants of the metabolic syndrome
Phillips, C. M., López‐Miranda, J., Pérez‐Jiménez, F., McManus, R., & Roche, H. M. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000221579.25878.11 · Cited by 114
Singh, S., Sarma, D. K., Verma, V., Nagpal, R., & Kumar, M. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.09.064 · Cited by 114
Sale, M. M., Smith, S. G., Mychaleckyj, J. C., Keene, K. L., Langefeld, C. D., Leak, T. S., Hicks, P. J., Bowden, D. W., Rich, S. S., & Freedman, B. I. (2007) · Diabetes · doi:10.2337/db07-0012 · Cited by 113
Mechanisms by which diabetes increases cardiovascular disease
Gleissner, C. A., Galkina, E., Nadler, J. L., & Ley, K. F. (2007) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2007.12.005 · Cited by 113
Urbanek, M., Sam, S., Legro, R. S., & Dunaif, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0761 · Cited by 113
Link-based quantitative methods to identify differentially coexpressed genes and gene Pairs
Yu, H., Liu, B., Ye, Z., Li, C., Li, Y., & Li, Y. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-315 · Cited by 112
Genetics of Type 2 Diabetes: Insights into the Pathogenesis and Its Clinical Application
Sun, X., Yu, W., & Hu, C. (2014) · BioMed Research International · doi:10.1155/2014/926713 · Cited by 111
Imamura, M., Maeda, S., Yamauchi, T., Hara, K., Yasuda, K., Morizono, T., Takahashi, A., Horikoshi, M., Nakamura, M., Fujita, H., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds113 · Cited by 111
Racialized Genetics and the Study of Complex Diseases: The Thrifty Genotype Revisited
Paradies, Y., Montoya, M. J., & Fullerton, S. M. (2007) · Perspectives in biology and medicine · doi:10.1353/pbm.2007.0020 · Cited by 111
A Genome-Wide Search for Type 2 Diabetes Susceptibility Genes in West Africans
Rotimi, C. N., Chen, G., Adeyemo, A., Furbert-Harris, P. M., Guass, D., Zhou, J., Berg, K. A., Adegoke, O. J., Amoah, A. G. B., Owusu, S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.3.838 · Cited by 111
McCarthy, M. I. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh057 · Cited by 110
DNA variations in human and medical genetics: 25 years of my experience
Nakamura, Y. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2008.6 · Cited by 110
Type-2 diabetes: a cocktail of genetic discovery
Freeman, H. C., & Cox, R. D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl191 · Cited by 110
Putting the genes for type II diabetes on the map
Almind, K., Doria, A., & Kahn, C. R. (2001) · Nature Medicine · doi:10.1038/85405 · Cited by 109
Hall, J. A., Ramachandran, D., Roh, H. C., DiSpirito, J. R., Belchior, T., Zushin, P. H., Palmer, C., Hong, S., Mina, A. I., Liu, B., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.016 · Cited by 109
Functional implications of genetic variation in human PPARγ
Jeninga, E. H., Gurnell, M., & Kalkhoven, E. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.04.005 · Cited by 109
Diabetes: A Candidate Disease for Efficient DNA Methylation Profiling
Maier, S., & Olek, A. (2002) · Journal of Nutrition · doi:10.1093/jn/132.8.2440s · Cited by 108
ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy
Müllenbach, R., Linton, K. J., Wiltshire, S., Weerasekera, N., Chambers, J., Elias, E., Higgins, C. F., Johnston, D. G., McCarthy, M. I., & Williamson, C. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.5.e70 · Cited by 108
Khunti, K., Kumar, S., & Brodie, J. (2009) · Cited by 108
Holmes, M. V., Shah, T., Vickery, C., Smeeth, L. L., Hingorani, A. D., & Casas, J. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007960 · Cited by 108
Soriguer, F., Morcillo, S., Cardona, F., Rojo‐Martínez, G., Almaraz, M. C., de Adana, M. S. R., Olveira, G., Tinahones, F. J., & Esteva, I. (2006) · Journal of Nutrition · doi:10.1093/jn/136.9.2325 · Cited by 108
Common variants in HNF-1 α and risk of type 2 diabetes
Holmkvist, J., Cervin, C., Lyssenko, V., Winckler, W., Anevski, D., Cilio, C., Almgren, P.-E., Berglund, G., Nilsson, P. M., Tuomilehto, J., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0450-x · Cited by 107
Self-citationPharmacogenetics of Anti-Diabetes Drugs
DiStefano, J. K., & Watanabe, R. M. (2010) · Pharmaceuticals · doi:10.3390/ph3082610 · Cited by 107
Cornelis, M. C., & Hu, F. B. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150648 · Cited by 107
Genetics of Type 2 Diabetes: Past, Present, and Future
Laakso, M., & Silva, L. F. (2022) · Nutrients · doi:10.3390/nu14153201 · Cited by 107
Progress in the genetics of common obesity and type 2 diabetes
Vimaleswaran, K. S., & Loos, R. J. F. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001389 · Cited by 107
Iwata, M., Maeda, S., Kamura, Y., Takano, A., Kato, H., Murakami, S., Higuchi, K., Takahashi, A., Fujita, H., Hara, K., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2006 · Cited by 107
The ENPP1 K121Q Polymorphism Is Associated With Type 2 Diabetes in European Populations
McAteer, J. B., Prudente, S., Bacci, S., Lyon, H. N., Hirschhorn, J. N., Trischitta, V., & Florez, J. C. (2007) · Diabetes · doi:10.2337/db07-1336 · Cited by 107
Self-citationSaadi, H., Nagelkerke, N. J. D., Carruthers, S. G., Benedict, S., Abdulkhalek, S., Reed, R. L., Lukić, M. L., & Nicholls, M. G. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.008 · Cited by 107
Ridker, P. M., Cook, N. R., Cheng, S., Erlich, H. A., Lindpaintner, K., Plutzky, J., & Zee, R. Y. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000068680.19521.34 · Cited by 107
Blackman, S. M., Hsu, S., Ritter, S. E., Naughton, K. M., Wright, F. A., Drumm, M. L., Knowles, M. R., & Cutting, G. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1436-2 · Cited by 106
Ludovico, O., Pellegrini, F., Paola, R. D., Minenna, A., Mastroianno, S., Cardellini, M., Marini, M. A., Andreozzi, F., Vaccaro, O., Sesti, G., et al. (2007) · Obesity · doi:10.1038/oby.2007.617 · Cited by 106
Genome-wide association with diabetes-related traits in the Framingham Heart Study
Meigs, J. B., Manning, A. K., Fox, C. S., Florez, J. C., Liu, C., Cupples, L. A., & Dupuis, J. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s16 · Cited by 106
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome
Orio, F., Matarese, G., Di Biase, S., Palomba, S., Labella, D., Sanna, V., Savastano, S., Zullo, F., Colao, A., & Lombardi, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021816 · Cited by 106
Hall, D., Gogos, J. A., & Karayiorgou, M. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2004.00078.x · Cited by 104
Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis
Vosper, H., Khoudoli, G. A., Graham, T. L., & Palmer, C. N. A. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00232-2 · Cited by 104
Are medical and nonmedical uses of large-scale genomic markers conflating genetics and 'race'?
Rotimi, C. N. (2004) · Nature Genetics · doi:10.1038/ng1439 · Cited by 104
Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus
Shaat, N., Ekelund, M., Lernmark, Å., Ivarsson, S. A., Almgren, P.-E., Berntorp, K. E., & Groop, L. (2005) · Diabetologia · doi:10.1007/s00125-005-0035-0 · Cited by 104
Self-citationYamada, N., Horikawa, Y., Oda, N., Iizuka, K., Shihara, N., Kishi, S., & Takeda, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0991 · Cited by 104
Approaches to identify genes for complex human diseases: Lessons from Mendelian disorders
Dean, M. C. (2003) · Human Mutation · doi:10.1002/humu.10259 · Cited by 104
Newton‐Cheh, C., Guo, C., Larson, M. G., Musone, S. L., Surti, A., Camargo, A. L., Drake, J. A., Benjamin, E. J., Levy, D. A., D’Agostino, R. B., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.710780 · Cited by 104
Self-citationGenetic approaches to the molecular understanding of type 2 diabetes
McCarthy, M. I., & Froguel, P. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00099.2002 · Cited by 103
Smith, J. G., Melander, O., Lövkvist, H., Hedblad, B., Engström, G., Nilsson, P. M., Carlson, J. A., Berglund, G. L., Norrving, B. G., & Lindgren, A. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.835173 · Cited by 103
Simón, I., Vendrell, J., Gutiérrez, C., Fernández-Real, J. M., Vendrell, I., Gallart, L., Fontova, R., & Richart, C. (2002) · Hormone Research in Paediatrics · doi:10.1159/000064490 · Cited by 103
Elbein, S. C., Chu, W. S., Das, S. K., Yao‐Borengasser, A., Hasstedt, S. J., Wang, H., Rasouli, N., & Kern, P. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0717-x · Cited by 103
Candidate Genes for Type 2 Diabetes
Parikh, H. M., & Groop, L. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000021437.46773.26 · Cited by 102
Self-citationType 2 diabetes mellitus: not quite exciting enough?
Ashcroft, F. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh066 · Cited by 102
Gene Expression Levels Are a Target of Recent Natural Selection in the Human Genome
Kudaravalli, S., Veyrieras, J.-B., Stranger, B. E., Dermitzakis, E. T., & Pritchard, J. K. (2008) · Molecular Biology and Evolution · doi:10.1093/molbev/msn289 · Cited by 102
Genetic Variation at the Adiponectin Locus and Risk of Type 2 Diabetes in Women
Hu, F. B., Doria, A., Li, T., Meigs, J. B., Liu, S., Memisoglu, A., Hunter, D., & Manson, J. E. (2004) · Diabetes · doi:10.2337/diabetes.53.1.209 · Cited by 102
Frayling, T. M., Beaumont, R. N., Jones, S. E., Yaghootkar, H., Tuke, M. A., Ruth, K. S., Casanova, F., West, B., Locke, J., Sharp, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.070 · Cited by 101
Self-citationWeiss, E. P., Brown, M. D., Shuldiner, A. R., & Hagberg, J. M. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00070.2001 · Cited by 101
Role of Calpain-10 Gene Variants in Familial Type 2 Diabetes in Caucasians
Elbein, S. C., Chu, W. S., Ren, Q., Hemphill, C., Schay, J., Cox, N. J., Hanis, C. L., & Hasstedt, S. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8210 · Cited by 101
Meirhaeghe, A., Fajas, L., Gouilleux, F., Cottel, D., Helbecque, N., Auwerx, J. H., & Amouyel, P. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000051382.28752.fe · Cited by 101
Alshali, K. Z., House, A. A., Hanley, A. J., Khan, H. M. R., Harris, S. B., Zinman, B., Mamakeesick, M., Fenster, A., Spence, J. D., & Hegele, R. A. (2004) · Stroke · doi:10.1161/01.str.0000138784.68159.a5 · Cited by 100
Genetics of Ovarian Disorders: Polycystic Ovary Syndrome
Franks, S., & McCarthy, M. I. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000016125.05878.96 · Cited by 100
Catchpole, B., Adams, J. P., Holder, A. L., Short, A. D., Ollier, W., & Kennedy, L. J. (2012) · The Veterinary Journal · doi:10.1016/j.tvjl.2012.11.013 · Cited by 100
Allen, T. L., Zhang, F., Moodie, S. A., Clemens, L. E., Smith, A. G., Gregoire, F. M., Bell, A., Muscat, G. E. O., & Gustafson, T. A. (2006) · Diabetes · doi:10.2337/db06-0618 · Cited by 100
The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity
Celi, F. S., & Shuldiner, A. R. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0078-2 · Cited by 99
Genomics of type 2 diabetes mellitus: implications for the clinician
Stolerman, E. S., & Florez, J. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.129 · Cited by 99
Jonsson, A., Ladenvall, C., Ahluwalia, T. S., Kravic, J., Krus, U., Taneera, J., Isomaa, B., Tuomi, T., Renström, E., Groop, L., et al. (2013) · Diabetes · doi:10.2337/db12-1627 · Cited by 99
Self-citationResistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes
Osawa, H., Onuma, H., Ochi, M., Murakami, A., Yamauchi, J., Takasuka, T., Tanabe, F., Shimizu, I., Kato, K., Nishida, W., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.122 · Cited by 99
Aprile, M., Ambrosio, M. R., D’Esposito, V., Bèguinot, F., Formisano, P., Costa, V., & Ciccodicola, A. (2014) · PPAR Research · doi:10.1155/2014/537865 · Cited by 99
Hanson, R. L., Bogardus, C., Duggan, D., Kobes, S., Knowlton, M., Infante, A. M., Marovich, L., Benitez, D., Baier, L. J., & Knowler, W. C. (2007) · Diabetes · doi:10.2337/db07-0462 · Cited by 98
Owen, K. R., & McCarthy, M. I. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.04.003 · Cited by 98
TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden
Mayans, S., Lackovic, K., Lindgren, P., Ruikka, K., Ågren, Å., Eliasson, M., & Holmberg, D. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201773 · Cited by 98
TCF7L2 genetic defect and type 2 diabetes
Cauchi, S., & Froguel, P. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0026-x · Cited by 97
Precision medicine in diabetes prevention, classification and management
Xie, F., Chan, J. C., & Ma, R. C. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12830 · Cited by 97
Association of DLG5 R30Q variant with inflammatory bowel disease
Daly, M. J., Pearce, A. V., Farwell, L. M., Fisher, S. A., Latiano, A., Prescott, N. J., Forbes, A., Mansfield, J. C., Sanderson, J. D., Langelier, D., et al. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201403 · Cited by 97
Self-citationWeedon, M. N., Owen, K. R., Shields, B., Hitman, G., Walker, M., McCarthy, M. I., Love-Gregory, L. D., Permutt, M. A., Hattersley, A. T., & Frayling, T. M. (2004) · Diabetes · doi:10.2337/diabetes.53.11.3002 · Cited by 96
Numakura, K., Satoh, S., Tsuchiya, N., Horikawa, Y., Inoue, T., Kakinuma, H., Matsuura, S., Saito, M., Tada, H., Suzuki, T., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000181142.82649.e3 · Cited by 96
Hellquist, A., Zucchelli, M., Kivinen, K., Saarialho‐Kere, U., Koskenmies, S., Widén, E., Julkunen, H. A., Wong, A., Karjalainen‐Lindsberg, M., Skoog, T., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.046185 · Cited by 96
Self-citationNetwork Medicine in Pathobiology
Lee, L. Y.-H., & Loscalzo, J. (2019) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.03.009 · Cited by 95
Hsueh, W.-C., Cole, S. A., Shuldiner, A. R., Beamer, B. A., Blangero, J., Hixson, J. E., MacCluer, J. W., & Mitchell, B. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.672 · Cited by 95
Tan, G. D., Neville, M. J., Liverani, E., Humphreys, S. M., Currie, J. M., Dennis, L., Fielding, B. A., & Karpe, F. (2005) · Diabetologia · doi:10.1007/s00125-005-0044-z · Cited by 94
Chang, M., Lindegren, M. L., Butler, M. A., Chanock, S. J., Dowling, N. F., Gallagher, M., Moonesinghe, R., Moore, C. A., Ned, R. M., Reichler, M. R., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn286 · Cited by 94
SORCS1: A Novel Human Type 2 Diabetes Susceptibility Gene Suggested by the Mouse
Goodarzi, M. O., Lehman, D. M., Taylor, K. D., Guo, X., Cui, J., Quiñones, M. J., Clee, S. M., Yandell, B. S., Blangero, J., Hsueh, W. A., et al. (2007) · Diabetes · doi:10.2337/db06-1677 · Cited by 93
Insulin signaling regulating genes: effect on T2DM and cardiovascular risk
Prudente, S., Morini, E., & Trischitta, V. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.215 · Cited by 93
Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies
Vasseur, F., Meyre, D., & Froguel, P. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406000147 · Cited by 93
Doney, A. S. F., Fischer, B., Leese, G., Morris, A. D., & Palmer, C. N. A. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000147897.57527.e4 · Cited by 93
Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants
Mohlke, K. L., Boehnke, M., & Abecasis, G. R. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn275 · Cited by 93
Systematic Search for Single Nucleotide Polymorphisms in the Resistin Gene
Osawa, H., Onuma, H., Murakami, A., Ochi, M., Nishimiya, T., Kato, K., Shimizu, I., Fujii, Y., Ohashi, J., & Makino, H. (2002) · Diabetes · doi:10.2337/diabetes.51.3.863 · Cited by 93
Muller, Y. L., Bogardus, C., Beamer, B. A., Shuldiner, A. R., & Baier, L. J. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1864 · Cited by 92
Unluturk, U., Harmanci, A., Kocaefe, C., & Yildiz, B. O. (2007) · PPAR Research · doi:10.1155/2007/49109 · Cited by 92
Metadata
- Authors
- Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., Tuomi, T., Gaudet, D., Hudson, T. J., Daly, M., Groop, L., & Lander, E. S.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Boston Children's Hospital (US)
- Lund University (SE)
- McGill University Health Centre (CA)
- Hôpital de Chicoutimi (CA)
- Corresponding author
- Lander, Eric S.
- ORCID
- Venue
- Nature Genetics
- Published
- 2000-09
- Volume
- 26
- Issue
- 1
- Pages
- 76-80
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1485161311
- Cited by
- 1,766
- References
- 40
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 11 · 2023: 20 · 2022: 22 · 2021: 28 · 2020: 20 · 2019: 27 · 2018: 32 · 2017: 28 · 2016: 63 · 2015: 37 · 2014: 62 · 2013: 75 · 2012: 75
- FWCI
- 31.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Corpus Université Laval (Université Laval) (submittedVersion)
- Funders
- Wellcome Trust (090532)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- type 2 diabetes, PPARγ, Pro12Ala polymorphism, genetic association, population stratification, replication, risk alleles, population attributable risk, diabetes pathogenesis
- MeSH terms
- Adult, Aged, Alanine, Alleles, Blood Glucose, Blood Pressure, Cholesterol, Diabetes Mellitus, Type 2, Family Health, Fathers, Female, Genotype, Humans, Lipoproteins, HDL, Male, Middle Aged, Models, Genetic, Mothers, Phenotype, Polymorphism, Genetic, Proline, Risk Factors, Transcription Factors, Linkage Disequilibrium, Body Mass Index, Age of Onset, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.